Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
- PMID: 9736021
- PMCID: PMC1853030
- DOI: 10.1016/s0002-9440(10)65614-3
Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
Abstract
Aggressive fibromatosis is a monoclonal proliferation of spindle (fibroblast-like) cells. A subset of lesions contain somatic truncating adenomatous polyposis coli (APC) gene mutations, and all of the lesions contain an elevated beta-catenin protein level. A major function of APC is to regulate beta-catenin protein level. Beta-catenin has a dual function in the cell: it is a member of the adherens junction, and it binds transcription factors in the tcf-lef family, transactivating transcription. Cell cultures from aggressive fibromatoses containing an APC mutation were studied. Transient transfection of the full-length APC gene caused decreased proliferation and beta-catenin protein level in these cultures. To determine whether beta-catenin protein level was responsible for the change in proliferation rate, stable transfections of deltaN89beta-catenin (a stabilized form that is not degraded by APC, but retains all other functions) were achieved in half of the cultures derived from each tumor, whereas the other half were transfected with an empty vector. Transfection of the full-length APC gene in cultures that were stably transfected with deltaN89beta-catenin did not result in a change in proliferation. The type I promotor of p56lck contains an HMG consensus region, to which members of the tcf-lef family can bind. p56lck was expressed in cultures not transfected with the full-length APC gene and in cultures transfected with the full-length APC gene and deltaN89beta-catenin, but not in cultures transfected with only the full-length APC gene. These data show that APC truncating mutations give aggressive fibromatosis cells a proliferative advantage through beta-catenin and suggest that beta-catenin acts to transactivate transcription.
Figures



Similar articles
-
Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).Am J Pathol. 1997 Aug;151(2):329-34. Am J Pathol. 1997. PMID: 9250146 Free PMC article.
-
A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.Clin Genet. 2000 Mar;57(3):205-12. doi: 10.1034/j.1399-0004.2000.570306.x. Clin Genet. 2000. PMID: 10782927
-
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).Oncogene. 1999 Nov 11;18(47):6615-20. doi: 10.1038/sj.onc.1203041. Oncogene. 1999. PMID: 10597266
-
The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).Eur J Surg Oncol. 2009 Jan;35(1):3-10. doi: 10.1016/j.ejso.2008.07.003. Epub 2008 Aug 21. Eur J Surg Oncol. 2009. PMID: 18722078 Review.
-
Analysis of Wnt/Beta catenin signalling in desmoid tumors.Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):5-9. Acta Gastroenterol Belg. 2005. PMID: 15832580 Review.
Cited by
-
Role of β-catenin expression in paediatric mesenchymal lesions: a tissue microarray-based immunohistochemical study.Eur J Histochem. 2012 Jul 2;56(3):e25. doi: 10.4081/ejh.2012.e25. Eur J Histochem. 2012. PMID: 23027341 Free PMC article.
-
Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.BMC Genomics. 2007 Apr 3;8:92. doi: 10.1186/1471-2164-8-92. BMC Genomics. 2007. PMID: 17407603 Free PMC article.
-
Targeted therapies: the rare cancer paradigm.Mol Oncol. 2010 Feb;4(1):19-37. doi: 10.1016/j.molonc.2009.10.003. Epub 2009 Oct 28. Mol Oncol. 2010. PMID: 19913465 Free PMC article. Review.
-
Distal Duodenal Stricture Secondary to Mesenteric Fibromatosis (Intra-Abdominal Desmoid Tumor) of the Jejunum.Case Rep Gastroenterol. 2024 Apr 20;18(1):231-237. doi: 10.1159/000538489. eCollection 2024 Jan-Dec. Case Rep Gastroenterol. 2024. PMID: 38645406 Free PMC article.
-
A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.Ann Surg. 2013 Aug;258(2):347-53. doi: 10.1097/SLA.0b013e31828c8a30. Ann Surg. 2013. PMID: 23532110 Free PMC article.
References
-
- Alman BA, Pajerski MA, Diaz-Cano S, Corboy K, Wolfe HJ: Aggressive fibromatosis (extra-abdominal desmoid) is a monoclonal disorder. Diagn Mol Pathol 1997, 6:98-101 - PubMed
-
- Li M, Cordon-Cardo C, Gerald WL, Rosai J: Desmoid fibromatosis is a clonal process. Hum Pathol 1996, 27:939-943 - PubMed
-
- Lucas DR, Shroyer KR, McCarthy PJ, Markham NE, Fujita M, Enomoto TE: Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol 1997, 21:306-311 - PubMed
-
- Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P: Binding of GSk3B to the APC-B-catenin complex and regulation of complex assembly. Science 1996, 272:8-26 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous